Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Imcyse

    Client Virtual Booth

    IMCYSE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Imcyse
    Belgium Flag
    Country
    Country
    Belgium
    Address
    Address
    GIGA B34 Avenue de l'Hôpital, 1 4000 Sart Tilman
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.imcyse.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of IMCY-0141
    Imcyse Announces Completion of Enrollment in Phase 1 Clinical Trial of IMCY-0141

    https://www.accesswire.com/viewarticle.aspx?id=783679&lang=en

    ACCESSWIRE
    13 Sep 2023
    Share Share
    Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098
    Imcyse Announces Completion of Enrollment in Phase 2 IMPACT Trial of IMCY-0098

    https://www.accesswire.com/viewarticle.aspx?id=741397&lang=en

    ACCESSWIRE
    01 Mar 2023
    Share Share
    Imcyse Begins Dosing in Adaptive Phase 1/2 Trial of Imotope IMCY-0141
    Imcyse Begins Dosing in Adaptive Phase 1/2 Trial of Imotope IMCY-0141

    https://www.globenewswire.com/news-release/2022/04/13/2421770/0/en/Imcyse-Announces-First-Patient-Dosed-in-Adaptive-Phase-1-2-Clinical-Trial-of-Imotope-IMCY-0141-for-Multiple-Sclerosis.html

    GLOBENEWSWIRE
    13 Apr 2022
    Share Share
    Imcyse to Present at Oppenheimer 32nd Annual Healthcare Conference
    Imcyse to Present at Oppenheimer 32nd Annual Healthcare Conference

    https://www.globenewswire.com/news-release/2022/03/14/2402419/0/en/Imcyse-to-Present-at-Oppenheimer-32nd-Annual-Healthcare-Conference.html

    GLOBENEWSWIRE
    14 Mar 2022
    Share Share
    Imcyse Reports +ve Immune Response from Phase 2 IMPACT Type 1 Diabetes Study
    Imcyse Reports +ve Immune Response from Phase 2 IMPACT Type 1 Diabetes Study

    https://www.globenewswire.com/news-release/2022/01/13/2366270/0/en/Imcyse-Reports-Positive-Immune-Response-from-Interim-Analysis-of-Phase-2-IMPACT-Type-1-Diabetes-Study.html

    GLOBENEWSWIRE
    13 Jan 2022
    Share Share
    Imcyse appoints Gene Mack as Chief Financial Officer
    Imcyse appoints Gene Mack as Chief Financial Officer

    http://www.pharmabiz.com/NewsDetails.aspx?aid=143765&sid=2

    PHARMABIZ
    08 Nov 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    polpharma-m-2024-04-15

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search